1 B for Cougar = 10 B for Dendreon.
Like a secondary offering at price X ever kept other stocks from falling through. New stock is usually offered near a short term peak in order to maximize cash return on those. How often does a biotech peak to raise money only to fall back to previous levels? Don't play with sectors you don't have a knowledge in.